Modules
Bellwood Medical Group, Inc.
Customer 7389
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ
- Assigned Reps
- Raymond Sutter
- Website
- —
- Active Opportunity Count
- 9
- Published Count
- 5
- Revenue Base
- 1290.3799999999999
- Known GPBase
- 658.35
- Analyzer Platforms
- Olympus / Beckman AU
- Product Groups
- Olympus
- Recommended Contact
- Jasper Sutcliffe
- Backup Contact
- Hana Palladino | Alt Contact | hana.palladino@bellwoodmedicalgroupinc.com
- Last Meaningful Activity
- 2025-01-02
- Customer Memory
- Verified transaction fact: platform/product group signal is Olympus / Beckman AU. Verified item fact: storage requirement N/A. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Olympus / Beckman AU. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-26c0ef500cc181a5b58dd29b9ac5e423f4b68ea63d8998fb4e164d8adb63e3da | Customer 7389 | Order 49229 | Item 5085 | Candidate CAND-74d2e88e5ae096a08f803f94813704a1d6a2fa6c568eb4a252586b255c616df3 | Customer 7389 | Order 51337 | Item 11360 | Candidate CAND-cbc8c6a9f9d7342026d0355041a3a098f55a5cbe1f7300585ff1c15ada2ad80e | Customer 7389 | Order 49122 | Item 11342 | Candidate CAND-6f239b83579f020334c325932aacf4089a3f7bb47abccddbae152dff98e6eda4 | Customer 7389 | Order 49229 | Item 11356 | Candidate CAND-fd7159ea5a62a3bcdc955a2fdd2a4164df45b228039766770f425e0d7f9e9292 | Customer 7389 | Order 49229 | Item 12164
Opportunities (13)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | OPP-e1066fe70160427f60bb9294097792fbef9313eace35690f4cdff655b10df898 | SER-c3b907c33a8cbef2256f877f1cf45adc889807748f1d4cb7c0d0f772ed242aba | Needs Validation | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $4069.59 versus $3422.73; trailing 180-day revenue $7492.32 versus $9881.05; -19 days beyond expected account order date. | 617.49 | 1234.98 | 1852.47 | 295.76 | 591.53 | 887.29 | 52.55 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | Customer 7389 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cbc8c6a9f9d7342026d0355041a3a098f55a5cbe1f7300585ff1c15ada2ad80e | OPP-55e8baddb74ec428f7f9a32229f2bd1e8da8927445de51cb35e59595459e34f8 | SER-9ac24f11abcbc44ddd6dd874313b07beb5953c41614ac0746876a3d1ddbda849 | Published | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6121 | OSR6121 Olympus Gluc Reagent (4x610 tests) | — | 49122 | 7 completed purchases over 777 days; median interval 128.0 days; expected reorder 2026-03-20; High Risk by 143 days. | 135.02 | 180.03 | 225.04 | 100.52 | 134.03 | 167.54 | 68.27 | Medium | False | False | — | CALL | Candidate CAND-cbc8c6a9f9d7342026d0355041a3a098f55a5cbe1f7300585ff1c15ada2ad80e | Customer 7389 | Order 49122 | Item 11342 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6f239b83579f020334c325932aacf4089a3f7bb47abccddbae152dff98e6eda4 | OPP-84b55fd1724ebf337c6ca5a4e8d7d2b660315e52aae9e17250921108235efcc3 | SER-24496b3a10cb40b4e1230f2a9a4b06e728ce419e13e66931b1770174ed59f673 | Published | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6102 | OSR6102 Olympus Albumin Reagent (4x620 tests) | — | 49229 | 7 completed purchases over 744 days; median interval 118.5 days; expected reorder 2026-03-11; High Risk by 152 days. | 149.51 | 199.35 | 249.19 | 133.76 | 178.35 | 222.94 | 67.96 | Medium | False | False | — | CALL | Candidate CAND-6f239b83579f020334c325932aacf4089a3f7bb47abccddbae152dff98e6eda4 | Customer 7389 | Order 49229 | Item 11356 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-26c0ef500cc181a5b58dd29b9ac5e423f4b68ea63d8998fb4e164d8adb63e3da | OPP-6a3fb7068ab31cd50d2921a1fc531a18a9dab7a145293c9fb71ff10c6331f8e3 | SER-4bd53b2e20d82cb36d245a76f2edb67f5f8533189ff9de9e4024f657f9956b90 | Published | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | MU988800 | MU988800 Olympus OEM Beckman Lamp for AU400, AU480, AU600, AU640, AU680 | — | 49229 | 6 completed purchases over 706 days; median interval 146.0 days; expected reorder 2026-04-13; High Risk by 119 days. | 270 | 360 | 450 | 127.69 | 170.25 | 212.81 | 65.88 | High | False | False | — | CALL | Candidate CAND-26c0ef500cc181a5b58dd29b9ac5e423f4b68ea63d8998fb4e164d8adb63e3da | Customer 7389 | Order 49229 | Item 5085 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fd7159ea5a62a3bcdc955a2fdd2a4164df45b228039766770f425e0d7f9e9292 | OPP-49312574554a7f7464fb5d1a342f5ca779717245bbfef5748ce587ce51ede288 | SER-bc192a1b47d5bfd7084f308eacdfb55e555b354ecef00bd461bda696cc04ce8a | Published | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6122 | OSR6122 Olympus PHOS (Inorganic Phosphorus) Reagent, 2 x 4 x 15 mL | — | 49229 | 7 completed purchases over 744 days; median interval 116.5 days; expected reorder 2026-03-26; High Risk by 137 days. | 114.75 | 153 | 191.25 | 88.13 | 117.51 | 146.89 | 65.71 | Medium | False | False | — | CALL | Candidate CAND-fd7159ea5a62a3bcdc955a2fdd2a4164df45b228039766770f425e0d7f9e9292 | Customer 7389 | Order 49229 | Item 12164 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-74d2e88e5ae096a08f803f94813704a1d6a2fa6c568eb4a252586b255c616df3 | OPP-a027478ca58187ceb5a1598978c046599d2b54914b5970b363d708c237b2263d | SER-c10b3b3a16da3c134d9c854bd2f11c3d313320634cacb39bacd137de310cd66f | Published | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6119 | OSR6119 Olympus GGT Reagent (4x310 tests), R1 4x18ml, R2 4x18ml | — | 51337 | 11 completed purchases over 950 days; median interval 95.5 days; expected reorder 2026-07-14; Overdue by 27 days. | 298.5 | 398 | 497.5 | 43.66 | 58.21 | 72.76 | 63.81 | High | False | False | — | CALL | Candidate CAND-74d2e88e5ae096a08f803f94813704a1d6a2fa6c568eb4a252586b255c616df3 | Customer 7389 | Order 51337 | Item 11360 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | OPP-12d64fe0ce2cfb160cdd17405fd4d6afdc417fed07384e5442af916b1b4eb17a | SER-57c17259276e4432a568083a52137a7ee214923da86f69f98f5d12e13241edfb | Needs Validation | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | MU919600 | MU919600 Beckman CL Electrode | — | 47963 | 5 completed purchases over 742 days; median interval 188.5 days; expected reorder 2026-02-26; High Risk by 165 days. | 390.75 | 521 | 651.25 | 81.83 | 109.11 | 136.39 | 61.98 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | Customer 7389 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | OPP-61ad1a648010572ae00e92579e789cd5c71bb82430b3291c35759550c34aa655 | SER-496787aa378e3db729deae7fc10eee0284855212d5cb1fee6deb1ffdd127ac0b | Needs Validation | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6132 | OSR6132 Olympus TP Reagent (4x750 tests) | — | 51337 | 8 completed purchases over 966 days; median interval 122.0 days; expected reorder 2026-08-25; Due Soon in 15 days. | 160.61 | 214.14 | 267.68 | 123.86 | 165.14 | 206.43 | 56.88 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | Customer 7389 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | OPP-5f90cd9f7c4f474d9698ae8913cd85f024475d70b9d00f0a3c4d0cee5c0b6001 | SER-61666cab66890272798471ccc0832da274002c1c416fff4d67d6d1b05a06febc | Needs Validation | **** | **** | **** | Bellwood Medical Group, Inc. | 7389 | HQ | Brewster | NY | Northeast | End-User Laboratory | High | Olympus / Beckman AU | Olympus | MU919400 | MU919400 Beckman Na Electrode | — | 47963 | 4 completed purchases over 742 days; median interval 273.0 days; expected reorder 2026-05-26; Overdue by 76 days. | 521 | 694.67 | 868.33 | 123.79 | 165.06 | 206.32 | 56.69 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | Customer 7389 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | OPP-e1066fe70160427f60bb9294097792fbef9313eace35690f4cdff655b10df898 | SER-c3b907c33a8cbef2256f877f1cf45adc889807748f1d4cb7c0d0f772ed242aba | — | **** | — | — | Bellwood Medical Group, Inc. | 7389 | HQ | — | NY | — | — | — | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $4069.59 versus $3422.73; trailing 180-day revenue $7492.32 versus $9881.05; -19 days beyond expected account order date. | — | 1234.98 | — | — | 591.53 | — | 52.55 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | Customer 7389 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | OPP-12d64fe0ce2cfb160cdd17405fd4d6afdc417fed07384e5442af916b1b4eb17a | SER-57c17259276e4432a568083a52137a7ee214923da86f69f98f5d12e13241edfb | — | **** | — | — | Bellwood Medical Group, Inc. | 7389 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 5 completed purchases over 742 days; median interval 188.5 days; expected reorder 2026-02-26; High Risk by 165 days. | — | 521 | — | — | 109.11 | — | 61.98 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | Customer 7389 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | OPP-61ad1a648010572ae00e92579e789cd5c71bb82430b3291c35759550c34aa655 | SER-496787aa378e3db729deae7fc10eee0284855212d5cb1fee6deb1ffdd127ac0b | — | **** | — | — | Bellwood Medical Group, Inc. | 7389 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 8 completed purchases over 966 days; median interval 122.0 days; expected reorder 2026-08-25; Due Soon in 15 days. | — | 214.14 | — | — | 165.14 | — | 56.88 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | Customer 7389 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | OPP-5f90cd9f7c4f474d9698ae8913cd85f024475d70b9d00f0a3c4d0cee5c0b6001 | SER-61666cab66890272798471ccc0832da274002c1c416fff4d67d6d1b05a06febc | — | **** | — | — | Bellwood Medical Group, Inc. | 7389 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 4 completed purchases over 742 days; median interval 273.0 days; expected reorder 2026-05-26; Overdue by 76 days. | — | 694.67 | — | — | 165.06 | — | 56.69 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | Customer 7389 |